Translational research at MOMA integrates clinical specimens and clinical studies with in vitro studies and molecular models of colon, bladder and prostate cancer diseases. MOMA is manifesting its international position by conducting translational research at a competitive level.
Comprehensive tissue banks including detailed clinical follow-up are established and maintained by MOMA in close cooperation with clinicians treating cancer patients.
Molecular classification of patients in relation to disease stage, prognosis, outcome and treatment and insight into molecular pathways in subgroups of patients are desired.
Bioinformatic modelling and large databases help to understand the importance of our molecular findings.
MOMA uses advanced techniques and equipment for investigating gene expression, genomic instability, genomic variation, several RNA species and laser microdissected tissues, and for functional classification of early molecular changes and pathways.
MOMA has modern laboratory facilities and computer equipment. See a list of equipment.